Company profile: Vicam
1.1 - Company Overview
Company description
- Provider of testing solutions to detect mycotoxins in raw materials, grains, and feeds; aflatoxins in food and feed products; Bisphenol A (BPA) in consumer products; citrinin in food and feed; deoxynivalenol (DON) in grains and feeds; and fumonisins in corn, to prevent contamination, ensure safety, and comply with safety regulations.
Products and services
- Aflatoxin Testing Solutions: Utilizes flagship immunoaffinity column for rapid, user-friendly detection of carcinogenic aflatoxins in food and feed products, enabling safety regulation compliance
- Mycotoxin Testing Solutions: Deploys rapid detection systems for mycotoxins in raw materials, grains, and feeds to prevent contamination and ensure safety throughout the feed chain
- Fumonisin Testing Solutions: Architects corn-associated detection systems to identify fumonisins found in corn, addressing risks linked to health issues in animals and humans
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vicam
SimplicityBio
HQ: Switzerland
Website
- Description: Provider of in-silico biomarker discovery programmes for companies and institutions, offering services in biomarker discovery and ranking, signature creation, and existent signature, delivering robust multi-biomarker signatures for the molecular diagnostic market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SimplicityBio company profile →
SenesTech
HQ: United States
Website
- Description: Provider of agricultural biotechnology life-sciences solutions for managing animal pest populations through fertility. Offers ContraPest, an EPA-registered liquid contraceptive that reduces rat fertility to control infestations, and Evolve, a soft bait that interferes with rodent reproductive mechanisms to prevent population growth.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SenesTech company profile →
Prellis Bio
HQ: United States
Website
- Description: Provider of holographic two-photon bioprinting and the EXIS™ platform that recreates human immunobiology in vitro using 3D-printed lymph node organoids for antibody discovery, immunogenicity evaluation, and tumor immune systems; services include fully human antibody libraries, vaccine R&D, and large 3D tissue models for disease modeling, ADME/Tox, regenerative medicine, and transplantation into animal models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prellis Bio company profile →
BioDot
HQ: United States
Website
- Description: Provider of automated low-volume, non-contact quantitative fluid dispensing systems and lamination, cutting, and assembly expertise. Platforms enable direct dispensing of lines and dots on membranes, papers, microwell plates, slides, and microfluidics, plus web handling and dip coating from roll stock and auto lamination, serving R&D through high-volume manufacturing in industrial, diagnostic, life science, and medical markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDot company profile →
Akoya Biosciences
HQ: United States
Website
- Description: Provider of end-to-end spatial biology solutions for high-parameter tissue analysis from biomarker discovery through clinical and translational research, enabling more precise therapies in immuno-oncology and drug development; offerings include PhenoCycler for spatial phenotyping at unprecedented speeds and PhenoImager for comprehensive tissue analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akoya Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vicam
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vicam
2.2 - Growth funds investing in similar companies to Vicam
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vicam
4.2 - Public trading comparable groups for Vicam
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →